Back to search
Triple-negative Breast Cancer and HR+/HER2- BC
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Triple-negative Breast Cancer and HR+/HER2- BC trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Triple-negative Breast Cancer and HR+/HER2- BC trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of Part 1 of this study is to evaluate the imaging characteristics, safety, biodistribution and pharmacokinetics of \[68Ga\]Ga-DFC413, and in Part 2…
This phase IIa trial studies how well dendritic cell vaccines against Her2/Her3 and pembrolizumab work for the treatment of triple negative breast cancer or HER…